J&J Brings Innovative Combo Nasal Spray To UK
Executive Summary
Following an Rx-to-OTC switch last year, J&J has launched its innovative dexpanthenol and xylometazoline combination nasal spray Sudafed Plus Blocked Nose in UK pharmacies.
You may also be interested in...
UK Product Approvals: J&J Expands Sudafed And Nicorette Offerings
The UK's MHRA has approved the Rx-to-OTC switch of J&J's Sudafed Plus nasal spray (xylometazoline hydrochloride/dexpanthenol) and given the green light for the company to add new pack sizes to its Nicorette QuickMist and QuickMist Smart Track products.
Winter Is Coming: CHC Firms Battle It Out In Germany’s Crowded Cough And Cold Market
Consumer healthcare firms large and small will fight it out this winter for dominance in Germany's OTC cough and cold market.
Life’s An Itch And Then You Cry – New Hay Fever Products And Campaigns In Germany This Spring
New OTC products and campaigns for the hay fever season from: GSK, Novartis, Dermapharm, Galenpharma, DHU and Thea Pharma.